Tissue perfusion mapping via dermal temperature sensors
The use of dermal temperature sensors to generate temperature time intensity curves addresses the invasiveness and contrast injection issues in tissue perfusion mapping, offering a non-invasive method for guiding treatment decisions in chronic limb-threatening ischemia.
Patent Information
- Application Number
- PCT/EP2024/063296
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-02
- Filing Date
- 2024-05-15
- Publication Date
- 2024-12-05
AI Technical Summary
Current methods for quantifying tissue perfusion in chronic limb-threatening ischemia are invasive or require contrast injection, which is problematic for patients with renal disease and non-healing wounds.
A system using dermal temperature sensors to measure temperature changes after a temperature-stimulative fluid injection, generating temperature time intensity curves to quantify tissue perfusion without invasiveness or contrast injection, allowing for dynamic perfusion mapping.
Enables non-invasive, effective tissue perfusion mapping that guides treatment decisions by providing dynamic perfusion parameters without the need for invasive procedures or contrast agents, particularly beneficial for patients with renal disease.
Smart Images

Figure EP2024063296_05122024_PF_FP_ABST
Abstract
Description
TISSUE PERFUSION MAPPING VIA DERMAE TEMPERATURE SENSORSBACKGROUND
[0001] Chronic limb-threatening ischemia (CLTI) is a severe condition of peripheral artery disease (PAD) leading to reduced blood flow (i.e., ischemia) to the foot and non-healing wounds. Quantifying tissue perfusion is important to diagnose chronic limb-threatening ischemia and to guide treatment decisions during vascular interventions of chronic limb-threatening ischemia.
[0002] Proper dynamic perfusion parameters are needed that describe the tissue at and / or near a wound compared to non-affected tissue to guide treatment decision making based on knowledge of whether a subject has sufficient perfusion to extremities such as a lower leg and foot. The proper dynamic perfusion parameters should be generated without a substantive degree of invasiveness or contrast injection, patients with non-healing wounds are often suffering from renal disease.SUMMARY
[0003] According to an aspect of the present disclosure, a controller includes an interface and a processing circuit. The interface is configured to receive measured temperature readings from each of a plurality of dermal temperature sensors. The processing circuit is configured to: receive the measured temperature readings following injection of a temperature-stimulative fluid; identify relative locations of each of the dermal temperature sensors as identified relative locations; generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves.
[0004] According to another aspect of the present disclosure, a method for tissue perfusion mapping includes receiving, from each of a plurality of dermal temperature sensors, measured temperature readings following injection of a temperature-stimulative fluid; identifying relative locations of each of the dermal temperature sensors as identified relative locations; generating temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermaltemperature sensors; and outputting data of the temperature time intensity curves.
[0005] According to another aspect of the present disclosure, a system includes a plurality of dermal temperature sensors and a controller. The controller includes an interface and a processing circuit. The interface is configured to receive measured temperature readings from each of the plurality of dermal temperature sensors. The processing circuit is configured to: receive the measured temperature readings following injection of a temperature-stimulative fluid; identify relative locations of each of the dermal temperature sensors as identified relative locations; generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves.
[0006] According to a further aspect of the present disclosure, a tangible, non-transitory computer-readable medium stores instructions. When executed by a processor, the instructions cause the processor to: receive measured temperature readings from each of a plurality of dermal temperature sensors following injection of a temperature-stimulative fluid; identify relative locations of each of the dermal temperature sensors as identified relative locations; generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves.BRIEF DESCRIPTION OF THE DRAWINGS
[0007] The example embodiments are best understood from the following detailed description when read with the accompanying drawing figures. It is emphasized that the various features are not necessarily drawn to scale. In fact, the dimensions may be arbitrarily increased or decreased for clarity of discussion. Wherever applicable and practical, like reference numerals refer to like elements.
[0008] FIG. 1 illustrates a system for tissue perfusion mapping via dermal temperature sensors, in accordance with a representative embodiment.
[0009] FIG. 2 illustrates another system for tissue perfusion mapping via dermal temperature sensors, in accordance with a representative embodiment.
[0010] FIG. 3A illustrates a graph of perceived intensity over time, in accordance with a representative embodiment.
[0011] FIG. 3B illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0012] FIG. 3C illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0013] FIG. 3D illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0014] FIG. 3E illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0015] FIG. 3F illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0016] FIG. 3G illustrates an information flow, in accordance with a representative embodiment.
[0017] FIG. 4 illustrates a method for tissue perfusion mapping via dermal temperature sensors, in accordance with a representative embodiment.
[0018] FIG. 5 illustrates a computer system, on which a method for tissue perfusion mapping via dermal temperature sensors is implemented, in accordance with another representative embodiment.DETAILED DESCRIPTION
[0019] In the following detailed description, for the purposes of explanation and not limitation, representative embodiments disclosing specific details are set forth in order to provide a thorough understanding of embodiments according to the present teachings. However, other embodiments consistent with the present disclosure that depart from specific details disclosed herein remain within the scope of the appended claims. Descriptions of known systems, devices, materials, methods of operation and methods of manufacture may be omitted so as to avoid obscuring the description of the representative embodiments. Nonetheless, systems, devices, materials and methods that are within the purview of one of ordinary skill in the art are within the scope of the present teachings and may be used in accordance with the representative embodiments. It is to be understood that the terminology used herein is for purposes of describing particular embodiments only and is not intended to be limiting. Definitions and explanations for terms herein are in addition to the technical and scientific meanings of the terms as commonly understood and accepted in the technical field of the present teachings.
[0020] It will be understood that, although the terms first, second, third etc. may be used herein to describe various elements or components, these elements or components should not be limited by these terms. These terms are only used to distinguish one element or component from another element or component. Thus, a first element or component discussed below could be termed a second element or component without departing from the teachings of the inventive concept.
[0021] As used in the specification and appended claims, the singular forms of terms ‘a’, ‘an’ and ‘the’ are intended to include both singular and plural forms, unless the context clearly dictates otherwise. Additionally, the terms "comprises", and / or "comprising," and / or similar terms when used in this specification, specify the presence of stated features, elements, and / or components, but do not preclude the presence or addition of one or more other features, elements, components, and / or groups thereof. As used herein, the term "and / or" includes any and all combinations of one or more of the associated listed items.
[0022] Unless otherwise noted, when an element or component is said to be “connected to”, “coupled to”, or “adjacent to” another element or component, it will be understood that the element or component can be directly connected or coupled to the other element or component, or intervening elements or components may be present. That is, these and similar terms encompass cases where one or more intermediate elements or components may be employed to connect two elements or components. However, when an element or component is said to be “directly connected” to another element or component, this encompasses only cases where the two elements or components are connected to each other without any intermediate or intervening elements or components.
[0023] The present disclosure, through one or more of its various aspects, embodiments and / or specific features or sub-components, is thus intended to bring out one or more of the advantages as specifically noted below.
[0024] As described herein, tissue perfusion mapping via dermal temperature sensors may be used in the field of peripheral vascular procedures, and particularly in treatment of peripheral artery disease and chronic limb threatening ischemia. Sensitive temperature sensors may be applied on the skin of the lower leg and foot to measure the distribution of skin perfusion.
[0025] FIG. 1 illustrates a system 100 for tissue perfusion mapping via dermal temperature sensors, in accordance with a representative embodiment.
[0026] The system 100 in FIG. 1 is a system for tissue perfusion mapping via dermaltemperature sensors and includes components that may be provided together or that may be distributed. The system 100 includes a first sensor 102, a second sensor 104, a first wire 112, a second wire 114, a controller 150, a processing circuit 152 and an interface 159. The first sensor 102 is connected to the interface 159 by the first wire 112. The second sensor 104 is connected to the interface by the second wire 114. The processing circuit 152 may comprise an applicationspecific integrated circuit or a combination of a memory that stores instructions and a processor that executes the instructions.
[0027] The first sensor 102 and the second sensor 104 are representative of one or more sensors which are very sensitive temperature sensors and which are applied on the skin of a peripheral limb such as on the lower leg and / or foot of a subject to measure the distribution of skin perfusion. Examples of the types of sensors used as the first sensor 102, the second sensor 104, and / or other sensors described herein include thermocouple sensors, thermistor sensors, fabry perrot sensors, mach zehnder sensors, fiber Bragg sensors, and optoelectronic oscillator sensors. Fiber Bragg sensors may be provided in optical fiber. The number of sensors in the system 100 may be as few as one and may be more than two, such as five or nine. The number of sensors used in the system 100 may not necessarily be fixed, and instead may vary based on the subject being measured and the reasons for the temperature readings. A bolus of cold saline may be injected into the blood stream of the subject, and temperature time intensity curves (T-TICs) may subsequently be determined using the first sensor 102 and the second sensor 104. In some embodiments, other types of fluids may be injected, such as typical contrast agents. The difference(s) between the temperature time intensity curves are determined to assess regional perfusion delta. The difference(s) between temperature time intensity curves may refer to comparisons between parameters obtained from the data for sensors. The parameters for each sensor may be compared to each other. A difference in perfusion may be obtained from different time points when comparing the same region, such as pre-intervention and post intervention or before and after medication. Times may also be stated relative to a time from one sensor, such as when an absolute time for an upstream sensor is earlier than an absolute time for one or more downstream sensor. The absolute time for data from one sensor may be subtracted from an absolute time for data from another sensor, so that timing is stated relatively. Examples of temperature time intensity curve parameters include bolus arrival time, maximum value, upslope, downslope, first derivative and second derivative, time to peak and area under the curve. Thebolus may be injected intravenously or intra-arterially, and the teachings herein are applicable to responsive tissue perfusion mapping both before an intervention, during an intervention, and after an intervention. Each of the first sensor, the second sensor 104 and any other sensor described herein may include a unique identification that distinguishes the sensor from any other sensor, and the unique identification may be sent with temperature readings, time of such temperature readings, and / or a sequence number of such temperature readings to assist with interpretation of the readings. In some embodiments, a communication standard may be developed so that temperature readings from sensors described herein are uniformly interpretable by controllers described herein.
[0028] The first wire 112 and the second wire 114 may be wires provided with the first sensor 102 and the second sensor 104, such as wires dedicated to such sensors.
[0029] The controller 150 may include more elements than the processing circuit 152 and the interface 159 depicted in FIG. 1. The controller 150 may be implemented in a patient monitor at a hospital or other medical facility, or in a medical apparatus dedicated to at least the functionality attributed to the controller 150 herein. The controller 150 may also or alternatively be placed in another type of console which is configured to connect to one or more sensors via wires. In some embodiments, the controller 150 may include another interface connected to another wire that leads to a patient monitor, such as when the controller 150 is provided in a medical apparatus separate from the patient monitor.
[0030] The processing circuit 152 may comprise a memory / processor combination, wherein the memory stores instructions and the processor executes the instructions. Also, or alternatively, the processing circuit 152 may comprise an application-specific integrated circuit (ASIC). The controller 150 may also include additional interfaces beyond the interface 159, such as a first interface, a second interface, a third interface, and a fourth interface. One or more of the interfaces may include ports, disk drives, wireless antennas, or other types of receiver circuitry that connect the controller 150 to other electronic elements. One or more of the interfaces may also include user interfaces such as buttons, keys, a mouse, a microphone, a speaker, a display, or other elements that users can use to interact with the controller 150 such as to enter instructions and receive output. The controller 150 may perform some of the operations described herein directly and may implement other operations described herein indirectly. For example, the controller 150 may directly control operations such as logical operations performed by theprocessing circuit 152 based on input received from the first sensor 102 and the second sensor 104 via the interface 159 and / or other interfaces.
[0031] The controller 150 may therefore include the interface 159, and the processing circuit 152. The interface may be configured to receive measured temperature readings from each of a plurality of dermal temperature sensors including the first sensor 102 and the second sensor 104. The processing circuit 152 may be configured to receive the measured temperature readings following injection of a temperature-stimulative fluid such as a saline bolus; and identify relative locations of each of the dermal temperature sensors as identified relative locations. The temperature-stimulative fluid may be injected manually or via a pump system. A pump system can be synchronized to the controller 150 so that the controller 150 knows when in time the injection occurs. The relative locations of each of the first sensor 102, the second sensor 104 and any other sensor being used may be identified by confirming that the clinician placing the sensors is following predetermined instructions which specify the locations to place the sensors. Locations for the sensors may be derived, for example, from angiosome regions on the foot. Alternatively, imaging and image analysis from a monitoring camera (not shown) may be used to identify the locations of the sensors. The processing circuit 152 may generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves. The controller 150 may output the data of the temperature time intensity curves on a display (not shown), or to another device or system over a network.
[0032] The output of the system 100 may include a perfusion map displayable on a display. The controller 150 may be used to assess dynamic perfusion parameters via the first sensor 102 and the second sensor 104, wherein the perfusion parameters may be dynamically stimulated by the temperature-stimulative fluid. The perfusion map may be color-coded as a heat map to show temperature and tissue perfusion of a subject’s extremity. The map may show the locations of the first sensor 102, the second sensor 104 and other dermal sensors, so as to map relative temperature and tissue perfusion in a manner that shows where perfusion may not be adequate. The parameter for each sensed location may be mapped, and such parameters may be indicative of temperature curve dynamics which reflect perfusion. Temperature is a proxy which is correlated to the perfusion of blood into tissue and capillaries. The map may be generated basedon processing by the controller 150. The map may be used to show whether perfusion has returned to a normal level after a blockage in an extremity is removed or otherwise treated.
[0033] FIG. 2 illustrates another system for tissue perfusion mapping via dermal temperature sensors, in accordance with a representative embodiment.
[0034] The system 200 in FIG. 2 includes a first sensor 202, a second sensor 204, a network 201, a controller 250 and a display 280. The controller 250 includes a memory 251, a processor 252, and a wireless interface 259.
[0035] The first sensor 202 and the second sensor 204 are again representative of one or more sensors which are very sensitive temperature sensors and which are applied on the skin of a peripheral limb such as the lower leg and / or foot to measure the distribution of skin perfusion. In FIG. 2, the first sensor 202 and the second sensor 204 may be configured to communicate with the controller 250 via the network 201. For example, the first sensor 202 and the second sensor 204 may be configured to communicate via wireless fidelity (Wi-Fi) and / or via Bluetooth or near-field communications (NFC).
[0036] The system 200 may operate when a temperature-stimulative fluid such as a bolus of cold saline is first injected into the blood stream of a subject and the temperature time intensity curves are determined using the first sensor 202 and the second sensor 204. The controller 250 may identify relative locations of each of the first sensor 202 and the second sensor 204 as identified relative locations, based on received measured temperature readings from the first sensor and the second sensor following the injection of the temperature-stimulative fluid. The controller 250 may also generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors. The difference(s) between the temperature time intensity curves are determined to assess regional perfusion delta. The difference(s) between temperature time intensity curves may refer to comparisons between parameters obtained from the data for sensors, The parameters for each sensor may be compared to each other. A difference in perfusion may be obtained from different time points when comparing the same region, such as pre-intervention and post intervention or before and after medication. Times may also be stated relative to a time from one sensor, such as when an absolute time for an upstream sensor is earlier than an absolute time for one or more downstream sensor. The absolute time for data from one sensor may be subtracted from an absolute time for data from another sensor, so that timingis stated relatively. Examples of temperature time intensity curve parameters include bolus arrival time, maximum value upslope, downslope, first derivative and second derivative, time to peak and area under the curve. The bolus may be injected intravenously or intra-arterially, and the teachings herein are applicable to responsive tissue perfusion mapping both before an intervention, during an intervention, and after an intervention.
[0037] The controller 250 may again be implemented in a patient monitor or in a separate medical device configured to connect to the patient monitor. The controller 250 may also be implemented in a computer, including a computer dedicated to functionality such as that described herein as well as a general-purpose computer such as a workstation, tablet computer or laptop computer. The controller 250 includes at least a memory 251 that stores instructions and a processor 252 that executes the instructions. However, in some embodiments, the controller 250 may also or alternatively have an application-specific integrated circuit that performs the logical operations attributed to the controller 250 herein. A computer that can be used to implement the controller 250 is depicted in FIG. 5, though a controller 250 may include more or fewer elements than depicted in FIG. 2 or FIG. 5.
[0038] A controller 250 may include more elements or fewer elements than depicted in FIG. 2. The controller 250 may include additional interfaces beyond the wireless interface 259, such as a first interface, a second interface, a third interface, and a fourth interface. One or more of the interfaces may include ports, disk drives, wireless antennas, or other types of receiver circuitry that connect the controller 250 to other electronic elements. One or more of the interfaces may also include user interfaces such as buttons, keys, a mouse, a microphone, a speaker, a display, or other elements that users can use to interact with the controller 250 such as to enter instructions and receive output. The controller 250 may perform some of the operations described herein directly and may implement other operations described herein indirectly. For example, the controller 250 may indirectly control operations such as by generating and transmitting content to be displayed on the display 280. The controller 250 may directly control other operations such as logical operations performed by the processor 252 executing instructions from the memory 251 based on input received from the first sensor 202 and the second sensor 204 via the network 201 and the wireless interface 259. Accordingly, the processes implemented by the controller 250 when the processor 252 executes instructions from the memory 251 may include steps not directly performed by the controller 250.
[0039] The wireless interface 259 may comprise a port and an antenna configured to transmit wireless signals, such as wireless fidelity (Wi-Fi) signals. In some embodiments, the wireless interface 259 may also or alternatively be configured to communicate over a wireless wide area network (WAN), such as a long term evolution (LTE) or a fifth generation (5G) network.
[0040] The display 280 may be local to the controller 250 or may be remotely connected to the controller 250. The display 280 may be connected to the controller 250 via a local wired interface such as an Ethernet cable or via a local wireless interface such as a Wi-Fi connection. The display 280 may be interfaced with other user input devices by which users can input instructions, including mouses, keyboards, thumbwheels and so on. The display 280 may be a monitor such as a computer monitor, a display on a mobile device, an augmented reality display, a television, an electronic whiteboard, or another screen configured to display electronic imagery. The display 280 may also include one or more input interface(s) such as those noted above that may connect to other elements or components, as well as an interactive touch screen configured to display prompts to users and collect touch input from users.
[0041] The output of the system 200 may include a perfusion map displayable on a display. The controller 250 may be used to assess dynamic perfusion parameters via the first sensor 202 and the second sensor 204, wherein the perfusion parameters may be dynamically stimulated by the temperature-stimulative fluid. The perfusion map may be color-coded as a heat map to show temperature and / or tissue perfusion of a subject’s extremity. The map may show the locations of the first sensor 202, the second sensor 204 and other dermal sensors, so as to map relative temperature and tissue perfusion in a manner that shows where perfusion may not be adequate. The map may be generated based on processing by the controller 250. The map may be used to show whether perfusion has returned to a normal level after a blockage in an extremity is removed or otherwise treated.
[0042] Opening up a vessel in a subject yields increased temperature in the peripheral limb such as the lower leg and / or foot. In an alternative to Bragg grating sensors provided in an optical fiber, each of a set of dermal temperature sensors may comprise a fiber optical realshape (FORS) sensor used to obtain temperature and three-dimensional (3D) spatial coordinates. With three- dimensional spatial coordinates, the temperature time intensity curve results or only temperature may be mapped to three-dimensional pre-operative computerized tomography angiogram (CTA) and / or magnetic resonance angiogram (MRA). A C-arm and fiber optic realshape (FORS) maybe tracked in cathlab coordinates so that temperature measurements may be easily matched to an angiogram to view the treatment impact. Other temperature sensor types may include NTC thermistor sensors, thermocouple sensors, resistance temperature detector sensors and semiconductor based temperature sensors.
[0043] In another set of embodiments, the sensors may be embedded into a sock to have sensor positions better defined. For example, the first sensor 202 and the second sensor 204 may be embedded with three other sensors at specific positions in a sock, so that the relative locations are pre-identified. Pre-identified locations of sensors may minimize the amount of processing required by the controllers described herein.
[0044] In another set of embodiments, effects of vasoactive compounds may be assessed preinfusion and post-infusion. For example temperature and tissue perfusion may be analyzed for a period before a vasoactive compound is injected into a subject, and then for a period after the vasoactive compound is injected into the subject, to determine whether the intended result of the injection is occurring.
[0045] In some embodiments, a reference sensor on a healthy leg may be used with room temperature as an input parameter. The reference sensor may be placed on a healthy leg or one or more other skin location(s) of the patient, or of a bench model in the room, or on a digital twin. In the case of placement of a reference sensor on a healthy leg, a bolus of fluid may need to be injected in the aorta or intravenously, to ensure the bolus will reach the healthy leg. The reference sensor may be uniquely identified among the sensors being used, and temperature of the reference sensor may be displayed on a user interface. The reference sensor may also be used to calibrate signals and parameters from other sensors in some embodiments, to ensure accuracy as a baseline relative to other sensors.
[0046] FIG. 3A illustrates a graph of perceived intensity over time, in accordance with a representative embodiment.
[0047] In FIG. 3A, dynamic parameters derivable from perceived intensity over time include time to peak, amplitude, upslope and downslope. As shown, perceived intensity increases from the start time tstart to the maximum time tmax, then plateaus, and then decreases from the plateau to the end time tend. A first regression line is fit to the increasing part of the graph as a regression line of increase. A second regression line is fit to the decreasing part of the graph as a regression line of decrease.
[0048] In FIG. 3 A, the time to peak equals the difference between the maximum time tmax and the start time tstart. The amplitude equals the magnitude of the perceived intensity at the maximum time tmax, and is expressed as imax. The upslope may be calculated as the amplitude imax over the time to peak. The downslope may be calculated as the amplitude imax over the difference between the end time tend and the maximum time tmax. An area under the curve may be calculated as the area under the graph of perceived intensity over time.
[0049] FIG. 3B illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0050] In FIG. 3B, three different time intensity curves are shown for three different locations, such as three different locations on the lower leg and / or foot of a subject. The time intensity curve for the first location may be a reference curve for a reference sensor, and may reflect a relatively healthy location. The time intensity curve for the third location may be for a sensor placed nearest to a wound, and may reflect a relatively diseased location or a region downstream of an arterial narrowing.
[0051] FIG. 3C illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0052] In FIG. 3C, a first graph on the left show three time intensity curves before a treatment, and the second graph on the right shows three corresponding time intensity curves after a treatment.
[0053] FIG. 3D illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0054] In FIG. 3D, a first graph on the left shows three time intensity curves before a treatment comprising an infusion of hyperemic drugs, and the second graph on the right shows three corresponding time intensity curves after the treatment comprising an infusion of hyperemic drugs. The effect of injection of one or more hyperemic drug(s) in pre-treatment is shown in FIG. 3D, with a narrowing in one of the supplying arteries of region 3. Examples of hyperemic drugs include adenosine and papaverine. In the disease region, the arterioles are already fully open to compensate for the upstream lesion, such that perfusion cannot be increased from these arterioles, and this results in a reduced response to the hyperemic drug. So in the pre-treatment, the healthy region will increase perfusion due to the drug(s) but the diseased region cannot.
[0055] FIG. 3E illustrates comparative temperature time intensity curves, in accordance with arepresentative embodiment.
[0056] In FIG. 3E, a first graph on the left shows three time intensity curves before a treatment comprising an infusion of hyperemic drugs, and the second graph on the right shows three corresponding time intensity curves after the treatment comprising an infusion of hyperemic drugs. In the post treatment situation shown in FIG. 3E, the lesion has been removed. As a result of the pre-infusion of drug(s), the TTICs are similar as the right graph of Fig 3C. Post-infusion of drug(s) the region downstream of the treated lesion will respond to the drug more similarly as the healthy reference region.
[0057] FIG. 3F illustrates comparative temperature time intensity curves, in accordance with a representative embodiment.
[0058] In FIG. 3F, two charts on the top show pre intervention intensity curves before and after infusion of hyperemic drugs, and two charts on the bottom show post intervention intensity curves.
[0059] FIG. 3G illustrates an information flow, in accordance with a representative embodiment.
[0060] In FIG. 3G, three sensors are placed on and / or around a foot on the left, and time intensity curves are recorded from the three placed sensors and from a reference sensor. The time intensity curves from the three placed sensors are recorded from an acquired signal for a time interval. The time intensity curves are then pre-processed for detrending and filtering.Afterwards, time intensity curve parameters are extracted from the pre-processed time intensity curves. The extracted parameters may include absolute parameters, relative parameters, and differences between absolute parameters and differences between relative parameters. Perfusion and / or relative perfusion may be color mapped based on the parameters. Additionally, the processing may include comparisons with comparable parameters from another measurement.
[0061] FIG. 4 illustrates a method for tissue perfusion mapping via dermal temperature sensors, in accordance with a representative embodiment.
[0062] The method of FIG. 4 may be performed by the system 100 including the controller 150, and / or by the system 200 including the controller 250. The method of FIG. 4 may be used to assess dynamic perfusion parameters via multiple temperature sensors on the skin. Physicians can measure temperature measurements at different locations in the lower leg and foot which indicate the perfusion from the larger vessels to the foot, and changes in the measurements over time pre-treatment, during treatment, and post-treatment to monitor opening up of blood vesselsand how blood pulse arrival times change from the larger vessels towards the foot.
[0063] The method of FIG. 4 starts at S402 by placing sensors. For example, the first sensor 102, the second sensor 104 and any other sensors being used in the wired embodiment of FIG. 1 may be placed on a lower leg of a subject. In some embodiments, a reference sensor may also be placed on another leg of the subject.
[0064] At S404, a fluid is injected. The injected fluid may be a bolus of saline. The time of the fluid injection may be input to the controller 150 or the controller 250, so that temperature measurements before and after the injection can be distinguished.
[0065] At S410, each sensor measures temperature and transmits a corresponding measured temperature reading. Each sensor may transmit a sensor identification, a temperature, a time of the measurement, and a sequence of the measurement. Sensors may also transmit other information required by a communication standard.
[0066] At S420, a controller receives measured temperature readings. The controller 150 may receive the measured temperature readings by the interface 159, or the controller 250 may receive the measured temperature readings by the wireless interface 259. The controller may also receive or otherwise determine relative locations of each of the dermal temperature sensors based on receiving the measured temperature readings. Using FORS fibers, distributed Bragg elements are placed at defined locations on the FORS fibers so that relative position may be automatically quantified. In other embodiments, predefined locations may not be automatically detectable, so that users may be provided instructions and guidance as to where the sensors should be placed. In embodiments in which angiosome coverage is sought, a sock with pre-defined locations may be places near or on a wound based on the disease symptoms of the skin. Instructions may be provided to a user on a user interface showing, for example, a 3 -dimensional model. In some embodiments, a 3 -dimensional model used to provide instructions may be segmented. In some embodiments, other types of technology may be used to location sensors. Other types of technology usable to locate sensors may include TOF technology, Wi-Fi, Bluetooth, Near Field Communication and / or RFID.
[0067] At S425, filtering is performed. Filtering in the method of FIG. 4 may include filtering out signal components to pre-process the temperature time intensity curves. Filtering may be performed at S425 to eliminate non-informative or unwanted signal components, such as baseline drifts and / or high frequency measurement noise. Filtering may include eliminatingoutlier readings, such as readings that are 5 degrees Fahrenheit higher or lower than adjacent readings taken within a 5 seconds before and after the outlier readings. Thresholds other than 5 degrees Fahrenheit and 5 second time variations may be used.
[0068] At S430, temperature time intensity curves are generated based on recorded measured temperature readings over time. The temperature time intensity curves may be generated and then updated based on each new measured temperature reading received at S420 after filtering at S425. For example, the temperature time intensity curves may comprise data arranged in order, such as in a row or column for each sensor being used.
[0069] At S440, temperature time intensity curves are displayed based on the measured temperature readings over time. For example, a controller may be configured to output data of the temperature time intensity curve to a display for displaying on the display 280 in FIG. 2. The temperature time intensity curves may be displayed as a display of skin perfusion distribution.
[0070] At S450, dynamic perfusion parameters are generated based on the temperature time intensity curves. The dynamic perfusion parameters may be generated based on identified relative locations, measured temperature readings for each identified relative location, and expected changes to a temperature baseline in the measured temperature readings. The temperature baseline may be taken into account insofar as a drift may be expected in some circumstances such as after a bolus of saline is injected. The bolus causes changes to a baseline, i.e., deviations which are recorded as T-TICs to extract the parameters from. The baseline may also shift by restoring tissue perfusion to a foot during an intervention, and this effect may be measured and used. When baseline is filtered out to obtain the parameters generated at S450, an average temperature recording of a time interval before and after the treatment may still be used to receive the warming due to re-perfusion information based on the difference between the before temperature and the after temperature. When perfusion is restored during an intervention, a temperature baseline may also rise, such as when the extremity gets warmer. The expected rise of the temperature baseline may be taken into account when generating the dynamic perfusion parameters, as this change in the temperature baseline otherwise affects the data and the visualization of the data. At or after S450, dynamic perfusion parameters generated based on T- TICs at S450 may be displayed for each sensor. For example, the dynamic perfusion parameters may be color coded to correspond to color coding for the T-TICs displayed at S440. The dynamic perfusion parameters may be displayed with the T-TICs while the T-TICs are stilldisplayed from S440 or separately from the T-TICs after the display of T-TICs at S440 ends.
[0071] At S470, the dynamic perfusion parameters and regional perfusion delta are assessed. For example, dynamic perfusion parameters may be generated from a first temperature time intensity curve before infusion of a vasoactive compound, and separately from a second temperature time intensity curve after infusion of the vasoactive compound, and differences between the temperature time intensity curves may be determined. The dynamic perfusion parameters may reflect the relative health of different areas of tissue around the sensors.
[0072] At S475, differences between perfusion parameters are displayed. The differences may be determined based on the assessment(s) at S470. The differences may reflect relative health of tissue around each sensor, so that differences between measurements from different sensors may be used to generate color display at S475 with heat patterns as a perfusion map showing relatively healthy perfusion parameters and relatively unhealthy perfusion parameters.
[0073] At S480, a determination is made as to whether the temperature measurements from S410 have resulted in TTICs of sufficient quality for the user. The measurement sequence from and including S410 to S475 may be repeated for a state, such as for a state before a vasoactive drug injection or treatment or for a state after a vasoactive drug injection or treatment, when the measurement sequence is to be repeated for quality purposes or any other reason.
[0074] At S485, another determination is made as to whether one or more additional measurement(s) are needed to represent another state. For example, additional measurement(s) may be needed to represent a different state after injection of vasoactive drugs or after an intervention. If no additional measurements are needed (S485 = No), the method of FIG. 4 ends at S495. If one or more additional measurement(s) are needed (S485 = Yes) the method returns to S404 so that another temperature stimulative fluid is injected and the analysis from S410 to S485 is repeated.
[0075] As set forth above, based on the determination at S485, in some instances the assessment of dynamic perfusion parameters at S470 may comprise a comparison of dynamic perfusion parameters between measurement series of two different states. Based on the determination at S480, in some instances the assessment of dynamic perfusion parameters at S470 may comprise a repeated comparison of dynamic perfusion parameters for measurement series for a single state.
[0076] The method of FIG. 4 may be performed without specifically requiring a contrast or X-ray imaging, though contrast and X-ray imaging may be used in the context of FIG. 4 also. Other than the injection of a bolus, the method of FIG. 4 may be non-invasive.
[0077] FIG. 5 illustrates a computer system, on which a method for tissue perfusion mapping via dermal temperature sensors is implemented, in accordance with another representative embodiment.
[0078] Referring to FIG. 5, the computer system 500 includes a set of software instructions that can be executed to cause the computer system 500 to perform any of the methods or computer- based functions disclosed herein. The computer system 500 may operate as a standalone device or may be connected, for example, using a network 501, to other computer systems or peripheral devices. In embodiments, a computer system 500 performs logical processing based on digital signals received via an analog-to-digital converter.
[0079] In a networked deployment, the computer system 500 operates in the capacity of a server or as a client user computer in a server-client user network environment, or as a peer computer system in a peer-to-peer (or distributed) network environment. The computer system 500 can also be implemented as or incorporated into various devices, such as a patient monitor that includes a controller, a dedicated medical device, workstation that includes a controller, a stationary computer, a mobile computer, a personal computer (PC), a laptop computer, a tablet computer, or any other machine capable of executing a set of software instructions (sequential or otherwise) that specify actions to be taken by that machine. The computer system 500 can be incorporated as or in a device that in turn is in an integrated system that includes additional devices. In an embodiment, the computer system 500 can be implemented using electronic devices that provide voice, video or data communication. Further, while the computer system 500 is illustrated in the singular, the term “system” shall also be taken to include any collection of systems or sub-systems that individually or jointly execute a set, or multiple sets, of software instructions to perform one or more computer functions.
[0080] As illustrated in FIG. 5, the computer system 500 includes a processor 510. The processor 510 may be considered a representative example of a processor of a controller and executes instructions to implement some or all aspects of methods and processes described herein. The processor 510 is tangible and non-transitory. As used herein, the term “non- transitory” is to be interpreted not as an eternal characteristic of a state, but as a characteristic of a state that will last for a period. The term “non-transitory” specifically disavows fleetingcharacteristics such as characteristics of a carrier wave or signal or other forms that exist only transitorily in any place at any time. The processor 510 is an article of manufacture and / or a machine component. The processor 510 is configured to execute software instructions to perform functions as described in the various embodiments herein. The processor 510 may be a general- purpose processor or may be part of an application specific integrated circuit (ASIC). The processor 510 may also be a microprocessor, a microcomputer, a processor chip, a controller, a microcontroller, a digital signal processor (DSP), a state machine, or a programmable logic device. The processor 510 may also be a logical circuit, including a programmable gate array (PGA), such as a field programmable gate array (FPGA), or another type of circuit that includes discrete gate and / or transistor logic. The processor 510 may be a central processing unit (CPU), a graphics processing unit (GPU), or both. Additionally, any processor described herein may include multiple processors, parallel processors, or both. Multiple processors may be included in, or coupled to, a single device or multiple devices.
[0081] The term “processor” as used herein encompasses an electronic component able to execute a program or machine executable instruction. References to a computing device comprising “a processor” should be interpreted to include more than one processor or processing core, as in a multi-core processor. A processor may also refer to a collection of processors within a single computer system or distributed among multiple computer systems. The term computing device should also be interpreted to include a collection or network of computing devices each including a processor or processors. Programs have software instructions performed by one or multiple processors that may be within the same computing device or which may be distributed across multiple computing devices.
[0082] The computer system 500 further includes a main memory 520 and a static memory 530, where memories in the computer system 500 communicate with each other and the processor 510 via a bus 508. Either or both of the main memory 520 and the static memory 530 may be considered representative examples of a memory of a controller, and store instructions used to implement some or all aspects of methods and processes described herein. Memories described herein are tangible storage mediums for storing data and executable software instructions and are non-transitory during the time software instructions are stored therein. As used herein, the term “non-transitory” is to be interpreted not as an eternal characteristic of a state, but as a characteristic of a state that will last for a period. The term “non-transitory” specificallydisavows fleeting characteristics such as characteristics of a carrier wave or signal or other forms that exist only transitorily in any place at any time. The main memory 520 and the static memory 530 are articles of manufacture and / or machine components. The main memory 520 and the static memory 530 are computer-readable mediums from which data and executable software instructions can be read by a computer (e.g., the processor 510). Each of the main memory 520 and the static memory 530 may be implemented as one or more of random access memory (RAM), read only memory (ROM), flash memory, electrically programmable read only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), registers, a hard disk, a removable disk, tape, compact disk read only memory (CD-ROM), digital versatile disk (DVD), floppy disk, Blu-ray disk, or any other form of storage medium known in the art. The memories may be volatile or non-volatile, secure and / or encrypted, unsecure and / or unencrypted.
[0083] “Memory” is an example of a computer-readable storage medium. Computer memory is any memory which is directly accessible to a processor. Examples of computer memory include, but are not limited to RAM memory, registers, and register files. References to “computer memory” or “memory” should be interpreted as possibly being multiple memories. The memory may for instance be multiple memories within the same computer system. The memory may also be multiple memories distributed amongst multiple computer systems or computing devices.
[0084] As shown, the computer system 500 further includes a video display unit 550, such as a liquid crystal display (LCD), an organic light emitting diode (OLED), a flat panel display, a solid-state display, or a cathode ray tube (CRT), for example. Additionally, the computer system 500 includes an input device 560, such as a keyboard / virtual keyboard or touch-sensitive input screen or speech input with speech recognition, and a cursor control device 570, such as a mouse or touch-sensitive input screen or pad. The computer system 500 also optionally includes a disk drive unit 580, a signal generation device 590, such as a speaker or remote control, and / or a network interface device 540.
[0085] In an embodiment, as depicted in FIG. 5, the disk drive unit 580 includes a computer- readable medium 582 in which one or more sets of software instructions 584 (software) are embedded. The sets of software instructions 584 are read from the computer-readable medium 582 to be executed by the processor 510. Further, the software instructions 584, when executed by the processor 510, perform one or more steps of the methods and processes as described herein. In an embodiment, the software instructions 584 reside all or in part within the mainmemory 520, the static memory 530 and / or the processor 510 during execution by the computer system 500. Further, the computer-readable medium 582 may include software instructions 584 or receive and execute software instructions 584 responsive to a propagated signal, so that a device connected to a network 501 communicates voice, video or data over the network 501. The software instructions 584 may be transmitted or received over the network 501 via the network interface device 540.
[0086] In an embodiment, dedicated hardware implementations, such as application-specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), programmable logic arrays and other hardware components, are constructed to implement one or more of the methods described herein. One or more embodiments described herein may implement functions using two or more specific interconnected hardware modules or devices with related control and data signals that can be communicated between and through the modules. Accordingly, the present disclosure encompasses software, firmware, and hardware implementations. Nothing in the present application should be interpreted as being implemented or implementable solely with software and not hardware such as a tangible non-transitory processor and / or memory.
[0087] In accordance with various embodiments of the present disclosure, the methods described herein may be implemented using a hardware computer system that executes software programs. Further, in an exemplary, non-limited embodiment, implementations can include distributed processing, component / object distributed processing, and parallel processing. Virtual computer system processing may implement one or more of the methods or functionalities as described herein, and a processor described herein may be used to support a virtual processing environment.
[0088] Accordingly, tissue perfusion mapping via dermal temperature sensors may be used in the field of peripheral vascular procedures, and particularly in treatment of peripheral artery disease and chronic limb threatening ischemia. The tissue perfusion mapping may be used in a variety of contexts, including before, during and after a procedure to determine whether a blockage has been properly removed or otherwise treated.
[0089] Although tissue perfusion mapping via dermal temperature sensors has been described with reference to several exemplary embodiments, it is understood that the words that have been used are words of description and illustration, rather than words of limitation. Changes may be made within the purview of the appended claims, as presently stated and as amended, withoutdeparting from the scope and spirit of tissue perfusion mapping via dermal temperature sensors in its aspects. Although tissue perfusion mapping via dermal temperature sensors has been described with reference to particular means, materials and embodiments, tissue perfusion mapping via dermal temperature sensors is not intended to be limited to the particulars disclosed; rather tissue perfusion mapping via dermal temperature sensors extends to all functionally equivalent structures, methods, and uses such as are within the scope of the appended claims.
[0090] The illustrations of the embodiments described herein are intended to provide a general understanding of the structure of the various embodiments. The illustrations are not intended to serve as a complete description of all of the elements and features of the disclosure described herein. Many other embodiments may be apparent to those of skill in the art upon reviewing the disclosure. Other embodiments may be utilized and derived from the disclosure, such that structural and logical substitutions and changes may be made without departing from the scope of the disclosure. Additionally, the illustrations are merely representational and may not be drawn to scale. Certain proportions within the illustrations may be exaggerated, while other proportions may be minimized. Accordingly, the disclosure and the figures are to be regarded as illustrative rather than restrictive.
[0091] One or more embodiments of the disclosure may be referred to herein, individually and / or collectively, by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any particular invention or inventive concept. Moreover, although specific embodiments have been illustrated and described herein, it should be appreciated that any subsequent arrangement designed to achieve the same or similar purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all subsequent adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the description.
[0092] The Abstract of the Disclosure is provided to comply with 37 C.F.R. §1.72(b) and is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. In addition, in the foregoing Detailed Description, various features may be grouped together or described in a single embodiment for the purpose of streamlining the disclosure. This disclosure is not to be interpreted as reflecting an intention that the claimed embodiments require more features than are expressly recited in each claim. Rather, as thefollowing claims reflect, inventive subject matter may be directed to less than all of the features of any of the disclosed embodiments. Thus, the following claims are incorporated into the Detailed Description, with each claim standing on its own as defining separately claimed subject matter.
[0093] The preceding description of the disclosed embodiments is provided to enable any person skilled in the art to practice the concepts described in the present disclosure. As such, the above disclosed subject matter is to be considered illustrative, and not restrictive, and the appended claims are intended to cover all such modifications, enhancements, and other embodiments which fall within the true spirit and scope of the present disclosure. Thus, to the maximum extent allowed by law, the scope of the present disclosure is to be determined by the broadest permissible interpretation of the following claims and their equivalents and shall not be restricted or limited by the foregoing detailed description. 1
Claims
CLAIMS:
1. A controller (150), comprising: an interface (159) configured to receive measured temperature readings from each of a plurality of dermal temperature sensors; and a processing circuit (152) configured to: receive the measured temperature readings following injection of a temperature- stimulative fluid; identify relative locations of each of the dermal temperature sensors as identified relative locations; generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves.
2. The controller (150) of claim 1, further comprising: a memory (251) that stores instructions, wherein the processing circuit (152) comprises a processor (252) that executes the instructions, and wherein the processing circuit (152) is further configured to execute the instructions to filter out signal components to pre-process the temperature time intensity curves.
3. The controller (150) of claim 1, wherein the processing circuit (152) is further configured to: generate dynamic perfusion parameters, wherein the dynamic perfusion parameters are generated based on the temperature time intensity curves.
4. The controller (150) of claim 1, wherein the processing circuit (152) is further configured to: output data of the temperature time intensity curves to a display (280), wherein the temperature time intensity curves are displayed on the display (280).
5. The controller (150) of claim 1, wherein the processing circuit (152) is further configured to: determine differences between the temperature time intensity curves to assess regional perfusion delta.
6. The controller (150) of claim 5, wherein determining differences between the temperature time intensity curves comprises comparing dynamic perfusion parameters from a first temperature time intensity curve before infusion of a vasoactive compound and dynamic perfusion parameters from a second temperature time intensity curve after the infusion of the vasoactive compound.
7. The controller (150) of claim 5, wherein determining differences between the temperature time intensity curves comprises comparing dynamic perfusion parameters from a first temperature time intensity curve before an intervention and dynamic perfusion parameters from a second temperature time intensity curve after the intervention.
8. The controller (150) of claim 1, wherein the processing circuit (152) is further configured to: wherein each of the plurality of dermal temperature sensors comprise an optical fiber with a Bragg Grating sensor.
9. The controller (150) of claim 1, wherein the processing circuit (152) is further configured to: wherein each of the plurality of dermal temperature sensors comprises a fiber optical realshape (FORS) sensor.
10. A method for tissue perfusion mapping, comprising: receiving, from each of a plurality of dermal temperature sensors, measured temperature readings following injection of a temperature-stimulative fluid; identifying relative locations of each of the dermal temperature sensors as identified relative locations;generating temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and outputting data of the temperature time intensity curves.
11. The method of claim 10, further comprising: generating dynamic perfusion parameters based on the measured temperature readings and the identified relative locations, wherein the dynamic perfusion parameters are generated based on the temperature time intensity curves.
12. The method of claim 10, further comprising: displaying the temperature time intensity curves as a display (280) of skin perfusion distribution.
13. The method of claim 10, further comprising: determining differences between the temperature time intensity curves to assess regional perfusion delta.
14. The method of claim 10, wherein each of the plurality of dermal temperature sensors comprise an optical fiber with a Bragg Grating sensor.
15. The method of claim 10, wherein each of the plurality of dermal temperature sensors comprises a fiber optical realshape (FORS) sensor.
16. A system (100) comprising: a plurality of dermal temperature sensors; and a controller (150) comprising an interface (159) configured to receive measured temperature readings from each of the plurality of dermal temperature sensors, and a processing circuit (152) configured to: receive the measured temperature readings following injection of a temperature- stimulative fluid;identify relative locations of each of the dermal temperature sensors as identified relative locations; generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves.
17. A tangible, non-transitory computer-readable medium (582) that stores instructions, which when executed by a processor (252), cause the processor (252) to: receive measured temperature readings from each of a plurality of dermal temperature sensors following injection of a temperature-stimulative fluid; identify relative locations of each of the dermal temperature sensors as identified relative locations; generate temperature time intensity curves to quantify tissue perfusion towards an extremity based on the measured temperature readings and the identified relative locations of each of the dermal temperature sensors; and output data of the temperature time intensity curves.
Citation Information
Patent Citations
Iontophoresis challenge for monitoring cardiovascular status
US20070118045A1
Methods and Apparatus for Profiling Cardiovascular Vulnerability to Mental Stress
US20080081963A1
System for distributed blood flow measurement
US20140194757A1
Real Time CSF Flow Measurement System & Method
US20150045717A1
System for determining blood flow
US20190239755A1
